Antiphospholipid antibody syndrome presenting as transverse myelitis
The antiphospholipid syndrome (APS) is characterized by arterial and/or venous thrombosis and pregnancy morbidity in the presence of anticardiolipin antibodies and/or lupus anticoagulant. APS can occur either as a primary disorder or secondary to a connective tissue disease, most frequently systemic...
Gespeichert in:
Veröffentlicht in: | Egyptian Rheumatology and Rehabilitation 2015-10, Vol.42 (4), p.204-206 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The antiphospholipid syndrome (APS) is characterized by arterial and/or venous thrombosis and
pregnancy morbidity in the presence of anticardiolipin antibodies and/or lupus anticoagulant.
APS can occur either as a primary disorder or secondary to a connective tissue disease, most
frequently systemic lupus erythematosus. Central nervous system involvement is one of the
most prominent clinical manifestations of APS, and includes arterial and venous thrombotic
events, psychiatric features, and a variety of other nonthrombotic neurological syndromes.
Although the mechanism of neurological involvement in patients with APS is thought to be
thrombotic in origin and endothelial dysfunction associated with antiphospholipid antibodies.
APS presenting as acute transverse myelitis is very rarely seen with a prevalence rate of
1%. We are describing a foreigner female presenting as acute transverse myelitis which on
evaluation proved to be APS induced. So far, very few cases have been reported in literature
with APS as etiology. |
---|---|
ISSN: | 1110-161X 2090-3235 |
DOI: | 10.4103/1110-161X.168209 |